Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, R. H. | - |
dc.contributor.author | Chang, H. S. | - |
dc.contributor.author | Wong, M. L. | - |
dc.contributor.author | Choi, M. J. | - |
dc.contributor.author | Park, J. Y. | - |
dc.contributor.author | Lee, H. Y. | - |
dc.contributor.author | Jung, I. K. | - |
dc.contributor.author | Joe, S. H. | - |
dc.contributor.author | Kim, L. | - |
dc.contributor.author | Kim, S. H. | - |
dc.contributor.author | Kim, Y. K. | - |
dc.contributor.author | Han, C. S. | - |
dc.contributor.author | Ham, B. J. | - |
dc.contributor.author | Lee, H. J. | - |
dc.contributor.author | Ko, Y. H. | - |
dc.contributor.author | Lee, M. S. | - |
dc.contributor.author | Lee, M. S. | - |
dc.date.accessioned | 2021-09-07T22:15:58Z | - |
dc.date.available | 2021-09-07T22:15:58Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2010-12 | - |
dc.identifier.issn | 0269-8811 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/115142 | - |
dc.description.abstract | Brain-derived neurotrophic factor (BDNF) is a candidate molecule for influencing the clinical response to antidepressant treatment. The aims of this study were to determine the relationship between the Val66Met polymorphism in the BDNF gene and the response to mirtazapine in 243 Korean subjects with major depressive disorder (MDD). The reduction in the Hamilton Depression score over the 8-week treatment period was not influenced by BDNF V66M genotypes. A marginal effect of genotype on somatic anxiety score was observed at baseline (P = 0.047 in the dominant model). However, genotype-time interaction had no effect on somatic anxiety score after the 8-week a treatment period. Plasma BDNF levels tended to increase during mirtazapine treatment, although without statistical significance (P = 0.055). After 8 weeks of mirtazapine treatment, plasma BDNF levels were higher in Met allele homozygotes (1499.7 +/- 370.6 ng/mL) than in Val allele carriers (649.7 +/- 158.5 ng/mL, P = 0.049). Our results do not support the hypothesis that the Val66Met promoter polymorphism in the BDNF gene influences the therapeutic response to mirtazapine in Korean MDD patients. However, our data indicate that this polymorphism results in increased plasma BDNF after mirtazapine treatment. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.subject | FACTOR BDNF | - |
dc.subject | VAL66MET POLYMORPHISM | - |
dc.subject | MOLECULAR-CLONING | - |
dc.subject | ASSOCIATION | - |
dc.subject | EXPRESSION | - |
dc.subject | MOOD | - |
dc.subject | TOLERABILITY | - |
dc.subject | MONOAMINES | - |
dc.subject | DISORDER | - |
dc.subject | SURVIVAL | - |
dc.title | Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chang, H. S. | - |
dc.contributor.affiliatedAuthor | Park, J. Y. | - |
dc.contributor.affiliatedAuthor | Lee, H. Y. | - |
dc.contributor.affiliatedAuthor | Jung, I. K. | - |
dc.contributor.affiliatedAuthor | Joe, S. H. | - |
dc.contributor.affiliatedAuthor | Kim, L. | - |
dc.contributor.affiliatedAuthor | Kim, S. H. | - |
dc.contributor.affiliatedAuthor | Han, C. S. | - |
dc.contributor.affiliatedAuthor | Ham, B. J. | - |
dc.contributor.affiliatedAuthor | Lee, H. J. | - |
dc.contributor.affiliatedAuthor | Ko, Y. H. | - |
dc.contributor.affiliatedAuthor | Lee, M. S. | - |
dc.contributor.affiliatedAuthor | Lee, M. S. | - |
dc.identifier.doi | 10.1177/0269881109105457 | - |
dc.identifier.scopusid | 2-s2.0-78650079772 | - |
dc.identifier.wosid | 000285044500004 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PSYCHOPHARMACOLOGY, v.24, no.12, pp.1755 - 1763 | - |
dc.relation.isPartOf | JOURNAL OF PSYCHOPHARMACOLOGY | - |
dc.citation.title | JOURNAL OF PSYCHOPHARMACOLOGY | - |
dc.citation.volume | 24 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1755 | - |
dc.citation.endPage | 1763 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | FACTOR BDNF | - |
dc.subject.keywordPlus | VAL66MET POLYMORPHISM | - |
dc.subject.keywordPlus | MOLECULAR-CLONING | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MOOD | - |
dc.subject.keywordPlus | TOLERABILITY | - |
dc.subject.keywordPlus | MONOAMINES | - |
dc.subject.keywordPlus | DISORDER | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordAuthor | brain-derived neurotrophic factor | - |
dc.subject.keywordAuthor | gene polymorphisms | - |
dc.subject.keywordAuthor | major depression | - |
dc.subject.keywordAuthor | mirtazapine | - |
dc.subject.keywordAuthor | treatment response | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.